Enjoy complimentary customisation on priority with our Enterprise License!
The anti-inflammatory therapeutics market size is forecast to increase by USD 38.7 billion at a CAGR of 6.3% between 2023 and 2028. The market is experiencing significant growth due to several key trends. The increase in off-label use of anti-inflammatory drugs in various indications beyond their approved uses is driving market growth. Additionally, the emergence of novel anti-inflammatory drugs, including monoclonal antibodies and small molecules, is providing new treatment options for inflammatory diseases. Autoimmune diseases, such as RA, and respiratory diseases, like pneumonia, can lead to a cytokine storm, resulting in acute respiratory distress, acute lung injury, and multiple organ dysfunction. However, the market also faces challenges, such as the risks and uncertainties associated with anti-inflammatory biologics, including their high production costs, potential side effects, and complex administration routes. These factors are necessitating the development of more cost-effective and convenient delivery systems to enhance patient compliance and improve market penetration.
Overall, the market is poised for growth, driven by the increasing prevalence of inflammatory diseases and the development of innovative treatments.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Drug Class
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.